Tag: #Global Trends

Despite reporting fourth-quarter 2025 earnings that surpassed Wall Street forecasts, Gilead Sciences saw its stock drop by as much as... Read more

Roche has unveiled compelling Phase 3 data from the FENtrepid trial for fenebrutinib, an oral BTK inhibitor. The brain-penetrating medication... Read more

Eli Lilly (USA) and Innovent Biologics (China) have officially entered their seventh strategic collaboration agreement. This partnership is designed to... Read more

On February 5, 2026, the U.S. government officially unveiled TrumpRx.gov, a direct-to-consumer (DTC) web portal offering significant discounts on over... Read more

Swiss pharmaceutical giant Novartis has officially commenced construction of its new global biomedical research center in San Diego, California. This... Read more

The legal friction between Danish pharmaceutical giant Novo Nordisk and telehealth provider Hims & Hers has intensified. Even though Hims... Read more

Pharmaceutical giant Eli Lilly has reinforced its presence in immunology and oncology by announcing two major deals: the acquisition of... Read more

By the end of the 2025 fiscal year, Novartis CEO Vas Narasimhan saw his realized compensation climb by 30% to... Read more

Health authorities in the United Kingdom are closely monitoring 36 infants exhibiting symptoms of gastrointestinal poisoning after consuming recalled formula... Read more